Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Travere Therapeutics, Inc. (TVTX)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
31 Jan 2024
ROTE WILLIAM E.
SENIOR VICE PRESIDENT, R&D, Officer
Travere Therapeutics, Inc.
(TVTX)
83,310
-5%
4,764
$8.71
$41,495.10
SELL
31 Jan 2024
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER, Officer
Travere Therapeutics, Inc.
(TVTX)
52,017
-5%
2,820
$8.53
$24,057.98
SELL
31 Jan 2024
REED ELIZABETH E
SVP, GC & CORPORATE SECRETARY, Officer
Travere Therapeutics, Inc.
(TVTX)
78,860
-5%
4,764
$8.71
$41,495.31
SELL
31 Jan 2024
Heerma Peter
CHIEF COMMERCIAL OFFICER, Officer
Travere Therapeutics, Inc.
(TVTX)
99,503
-4%
4,195
$8.53
$35,788.80
SELL
31 Jan 2024
Inrig Jula
CHIEF MEDICAL OFFICER, Officer
Travere Therapeutics, Inc.
(TVTX)
58,074
-3%
2,174
$8.53
$18,546.61
SELL
31 Jan 2024
Cline Christopher R.
CHIEF FINANCIAL OFFICER, Officer
Travere Therapeutics, Inc.
(TVTX)
70,903
-5%
3,818
$8.53
$32,572.50
SELL
31 Jan 2024
Dube Eric M
CHIEF EXECUTIVE OFFICER, Director, Officer
Travere Therapeutics, Inc.
(TVTX)
360,616
-5%
19,122
$8.70
$166,435.06
SELL
23 Jan 2024
REED ELIZABETH E
SVP, GC & CORPORATE SECRETARY, Officer
Travere Therapeutics, Inc.
(TVTX)
56,034
-3%
2,062
$8.96
$18,475.52
SELL
23 Jan 2024
Dube Eric M
CHIEF EXECUTIVE OFFICER, Director, Officer
Travere Therapeutics, Inc.
(TVTX)
234,722
-3%
7,873
$8.96
$70,542.08
SELL
23 Jan 2024
Cline Christopher R.
CHIEF FINANCIAL OFFICER, Officer
Travere Therapeutics, Inc.
(TVTX)
49,721
-1%
853
$9.07
$7,735.35
SELL
23 Jan 2024
ROTE WILLIAM E.
SENIOR VICE PRESIDENT, R&D, Officer
Travere Therapeutics, Inc.
(TVTX)
60,484
-3%
2,062
$8.96
$18,475.52
SELL
23 Jan 2024
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER, Officer
Travere Therapeutics, Inc.
(TVTX)
41,337
-2%
910
$9.07
$8,252.24
SELL
23 Jan 2024
Heerma Peter
CHIEF COMMERCIAL OFFICER, Officer
Travere Therapeutics, Inc.
(TVTX)
78,698
-1%
1,559
$9.07
$14,137.64
SELL
3 Jan 2024
Inrig Jula
Chief Medical Officer, Officer
Travere Therapeutics, Inc.
(TVTX)
35,248
-6%
2,509
$9.43
$23,647.68
SELL
5 Sep 2023
Cline Christopher R.
Chief Financial Officer, Officer
Travere Therapeutics, Inc.
(TVTX)
50,574
-0%
457
$14.71
$6,722.56
SELL
31 Aug 2023
Dube Eric M
Chief Executive Officer, Director, Officer
Travere Therapeutics, Inc.
(TVTX)
242,595
-1%
4,455
$14.71
$65,533.05
SELL
31 Aug 2023
REED ELIZABETH E
SVP, GC & Corporate Secretary, Officer
Travere Therapeutics, Inc.
(TVTX)
58,096
-3%
1,815
$14.71
$26,698.65
SELL
31 Aug 2023
ROTE WILLIAM E.
Senior Vice President, R&D, Officer
Travere Therapeutics, Inc.
(TVTX)
61,173
-2%
1,815
$14.71
$26,698.65
SELL
11 Apr 2023
Cline Christopher R.
Chief Financial Officer, Officer
Travere Therapeutics, Inc.
(TVTX)
51,486
-0%
47
$21.49
$1,010.03
SELL
31 Jan 2023
Calvin Sandra
SVP, Chief Accounting Officer, Officer
Travere Therapeutics, Inc.
(TVTX)
42,805
-4%
2,031
$21.87
$44,418.79
SELL
31 Jan 2023
Dube Eric M
Chief Executive Officer, Director, Officer
Travere Therapeutics, Inc.
(TVTX)
237,150
-3%
8,196
$22.25
$182,361.00
SELL
31 Jan 2023
Cline Christopher R.
Chief Financial Officer, Officer
Travere Therapeutics, Inc.
(TVTX)
51,533
-2%
1,588
$21.75
$34,542.18
SELL
31 Jan 2023
Heerma Peter
Chief Commercial Officer, Officer
Travere Therapeutics, Inc.
(TVTX)
82,069
-2%
1,779
$21.75
$38,696.81
SELL
31 Jan 2023
ROTE WILLIAM E.
Senior Vice President, R&D, Officer
Travere Therapeutics, Inc.
(TVTX)
60,036
-4%
2,590
$22.25
$57,627.50
SELL
31 Jan 2023
REED ELIZABETH E
SVP, GC & Corporate Secretary, Officer
Travere Therapeutics, Inc.
(TVTX)
57,436
-4%
2,590
$22.25
$57,627.50
SELL
24 Jan 2023
Calvin Sandra
SVP, Chief Accounting Officer, Officer
Travere Therapeutics, Inc.
(TVTX)
34,836
-3%
1,097
$21.86
$23,976.44
SELL
24 Jan 2023
ROTE WILLIAM E.
Senior Vice President, R&D, Officer
Travere Therapeutics, Inc.
(TVTX)
42,376
-4%
2,062
$21.50
$44,333.00
SELL
24 Jan 2023
REED ELIZABETH E
SVP, GC & Corporate Secretary, Officer
Travere Therapeutics, Inc.
(TVTX)
39,776
-4%
2,062
$21.50
$44,333.00
SELL
24 Jan 2023
Dube Eric M
Chief Executive Officer, Director, Officer
Travere Therapeutics, Inc.
(TVTX)
147,846
-4%
6,442
$21.50
$138,503.00
SELL
24 Jan 2023
Cline Christopher R.
Chief Financial Officer, Officer
Travere Therapeutics, Inc.
(TVTX)
32,871
-2%
852
$21.90
$18,662.55
SELL
24 Jan 2023
Heerma Peter
Chief Commercial Officer, Officer
Travere Therapeutics, Inc.
(TVTX)
63,598
-2%
1,550
$21.90
$33,951.82
SELL
5 Jan 2023
Dube Eric M
Chief Executive Officer, Director, Officer
Travere Therapeutics, Inc.
(TVTX)
154,288
-3%
5,625
$20.75
$116,718.75
SELL
4 Jan 2023
Inrig Jula
Chief Medical Officer, Officer
Travere Therapeutics, Inc.
(TVTX)
17,507
-12%
2,493
$20.75
$51,729.75
SELL
4 Oct 2022
Heerma Peter
Chief Commercial Officer, Officer
Travere Therapeutics, Inc.
(TVTX)
65,148
-4%
3,042
$25.68
$78,118.56
SELL
13 Sep 2022
Calvin Sandra
SVP, Chief Accounting Officer, Officer
Travere Therapeutics, Inc.
(TVTX)
35,933
-0%
349
$28.00
$9,772.00
SELL
11 May 2022
ROTE WILLIAM E.
Senior Vice President, R&D, Officer
Travere Therapeutics, Inc.
(TVTX)
44,485
-3%
1,563
$21.71
$33,940.25
SELL
11 May 2022
ASELAGE STEVE
Director
Travere Therapeutics, Inc.
(TVTX)
146,919
-1%
2,575
$21.92
$56,456.62
SELL
10 May 2022
Calvin Sandra
SVP, Chief Accounting Officer, Officer
Travere Therapeutics, Inc.
(TVTX)
35,733
-2%
881
$21.72
$19,134.32
SELL
10 May 2022
REED ELIZABETH E
SVP, GC & Corporate Secretary, Officer
Travere Therapeutics, Inc.
(TVTX)
41,838
-4%
1,950
$21.51
$41,943.45
SELL
10 May 2022
Clague Laura
Chief Financial Officer, Officer
Travere Therapeutics, Inc.
(TVTX)
35,655
-5%
2,200
$21.51
$47,322.00
SELL
10 Feb 2022
Dube Eric M
Chief Executive Officer, Director, Officer
Travere Therapeutics, Inc.
(TVTX)
159,913
-2%
4,832
$27.84
$134,522.88
SELL
31 Jan 2022
Dube Eric M
Chief Executive Officer, Director, Officer
Travere Therapeutics, Inc.
(TVTX)
164,745
-2%
4,813
$27.40
$131,876.20
SELL
31 Jan 2022
Calvin Sandra
VP, Corp Controller and CAO, Officer
Travere Therapeutics, Inc.
(TVTX)
36,614
-2%
798
$26.51
$21,151.71
SELL
31 Jan 2022
Heerma Peter
Chief Commercial Officer, Officer
Travere Therapeutics, Inc.
(TVTX)
67,297
-1%
1,125
$27.40
$30,825.00
SELL
31 Jan 2022
REED ELIZABETH E
SVP, GC & Corporate Secretary, Officer
Travere Therapeutics, Inc.
(TVTX)
43,788
-2%
1,350
$27.40
$36,990.00
SELL
31 Jan 2022
ROTE WILLIAM E.
Senior Vice President, R&D, Officer
Travere Therapeutics, Inc.
(TVTX)
45,235
-2%
1,125
$27.40
$30,825.00
SELL
31 Jan 2022
Clague Laura
Chief Financial Officer, Officer
Travere Therapeutics, Inc.
(TVTX)
37,855
-3%
1,238
$27.40
$33,921.20
SELL
24 Jan 2022
Dube Eric M
Chief Executive Officer, Director, Officer
Travere Therapeutics, Inc.
(TVTX)
131,710
-5%
7,873
$24.98
$196,667.53
SELL
24 Jan 2022
Calvin Sandra
VP, Corp Controller and CAO, Officer
Travere Therapeutics, Inc.
(TVTX)
28,662
-3%
934
$24.58
$22,954.64
SELL
24 Jan 2022
Heerma Peter
Chief Commercial Officer, Officer
Travere Therapeutics, Inc.
(TVTX)
58,582
-3%
1,875
$24.98
$46,837.50
SELL
24 Jan 2022
ROTE WILLIAM E.
Senior Vice President, R&D, Officer
Travere Therapeutics, Inc.
(TVTX)
36,520
-4%
1,875
$24.98
$46,837.50
SELL
24 Jan 2022
REED ELIZABETH E
SVP, GC & Corporate Secretary, Officer
Travere Therapeutics, Inc.
(TVTX)
35,298
-5%
2,250
$24.98
$56,205.00
SELL
24 Jan 2022
Clague Laura
Chief Financial Officer, Officer
Travere Therapeutics, Inc.
(TVTX)
29,253
-6%
2,063
$24.98
$51,533.74
SELL
10 Jan 2022
REED ELIZABETH E
SVP, GC & Corporate Secretary, Officer
Travere Therapeutics, Inc.
(TVTX)
37,548
-11%
5,000
$27.40
$137,000.00
SELL
10 Jan 2022
ROTE WILLIAM E.
Senior Vice President, R&D, Officer
Travere Therapeutics, Inc.
(TVTX)
38,395
-6%
2,500
$27.40
$68,500.00
SELL
10 Jan 2022
Clague Laura
Chief Financial Officer, Officer
Travere Therapeutics, Inc.
(TVTX)
31,316
-19%
7,500
$27.40
$205,500.00
SELL
4 Jan 2022
Dube Eric M
Chief Executive Officer, Director, Officer
Travere Therapeutics, Inc.
(TVTX)
141,722
-10%
17,332
$30.08
$521,406.72
SELL
16 Nov 2021
ASELAGE STEVE
Director
Travere Therapeutics, Inc.
(TVTX)
149,494
-17%
31,800
$29.39
$934,602.00
SELL
5 Nov 2021
ASELAGE STEVE
Director
Travere Therapeutics, Inc.
(TVTX)
161,794
-5%
10,000
$26.23
$262,300.00
SELL
1 Nov 2021
ASELAGE STEVE
Director
Travere Therapeutics, Inc.
(TVTX)
19,500
-30%
8,500
$29.69
$252,400.00
SELL
7 Oct 2021
ASELAGE STEVE
Director
Travere Therapeutics, Inc.
(TVTX)
221,794
-21%
60,000
$26.25
$1,574,760.00
SELL
4 Oct 2021
Heerma Peter
Chief Commercial Officer, Officer
Travere Therapeutics, Inc.
(TVTX)
60,457
-4%
3,058
$24.77
$75,746.05
SELL
13 Aug 2021
Dube Eric M
Chief Executive Officer, Director, Officer
Travere Therapeutics, Inc.
(TVTX)
156,915
-4%
7,836
$17.12
$134,142.14
SELL
13 Aug 2021
Heerma Peter
Chief Commercial Officer, Officer
Travere Therapeutics, Inc.
(TVTX)
63,515
-2%
1,407
$17.12
$24,086.01
SELL
13 Aug 2021
Rosenberg Noah L.
Chief Medical Officer, Officer
Travere Therapeutics, Inc.
(TVTX)
47,614
-2%
1,407
$17.12
$24,085.03
SELL
13 Aug 2021
ROTE WILLIAM E.
Senior Vice President, R&D, Officer
Travere Therapeutics, Inc.
(TVTX)
35,731
-3%
1,407
$17.12
$24,085.45
SELL
13 Aug 2021
REED ELIZABETH E
SVP, GC & Corporate Secretary, Officer
Travere Therapeutics, Inc.
(TVTX)
37,548
-3%
1,407
$17.12
$24,086.01
SELL
13 Aug 2021
Clague Laura
Chief Financial Officer, Officer
Travere Therapeutics, Inc.
(TVTX)
31,316
-4%
1,407
$17.12
$24,085.31
SELL
28 Jul 2021
Rosenberg Noah L.
Chief Medical Officer, Officer
Travere Therapeutics, Inc.
(TVTX)
44,521
-2%
1,250
$13.81
$17,262.50
SELL
1 Jun 2021
Dube Eric M
Chief Executive Officer, Director, Officer
Travere Therapeutics, Inc.
(TVTX)
147,251
-6%
9,562
$14.62
$139,796.98
SELL
11 May 2021
Rosenberg Noah L.
Chief Medical Officer, Officer
Travere Therapeutics, Inc.
(TVTX)
45,594
-1%
750
$19.30
$14,475.00
SELL
11 May 2021
ROTE WILLIAM E.
Senior Vice President, R&D, Officer
Travere Therapeutics, Inc.
(TVTX)
31,707
-8%
3,125
$19.30
$60,312.34
SELL
11 May 2021
REED ELIZABETH E
SVP, GC & Corporate Secretary, Officer
Travere Therapeutics, Inc.
(TVTX)
34,455
-8%
3,250
$19.30
$62,725.00
SELL
11 May 2021
Clague Laura
Chief Financial Officer, Officer
Travere Therapeutics, Inc.
(TVTX)
28,223
-12%
4,000
$19.30
$77,200.00
SELL
11 May 2021
ASELAGE STEVE
Director
Travere Therapeutics, Inc.
(TVTX)
186,794
-1%
2,146
$19.58
$42,022.97
SELL
16 Apr 2021
ASELAGE STEVE
Director
Travere Therapeutics, Inc.
(TVTX)
188,940
-5%
10,000
$26.23
$262,300.00
SELL
17 Mar 2021
ASELAGE STEVE
Director
Travere Therapeutics, Inc.
(TVTX)
196,667
-8%
17,727
$27.44
$486,456.12
SELL
17 Feb 2021
ROTE WILLIAM E.
Senior Vice President, R&D, Officer
Travere Therapeutics, Inc.
(TVTX)
34,832
-6%
2,500
$28.01
$70,025.00
SELL
5 Feb 2021
Dube Eric M
Chief Executive Officer, Director, Officer
Travere Therapeutics, Inc.
(TVTX)
156,813
-5%
9,626
$31.49
$303,170.88
SELL
5 Feb 2021
Heerma Peter
Chief Commercial Officer, Officer
Travere Therapeutics, Inc.
(TVTX)
59,344
-3%
2,250
$31.49
$70,863.75
SELL
5 Feb 2021
Rosenberg Noah L.
Chief Medical Officer, Officer
Travere Therapeutics, Inc.
(TVTX)
46,344
-4%
2,250
$31.49
$70,863.75
SELL
5 Feb 2021
ROTE WILLIAM E.
Senior Vice President, R&D, Officer
Travere Therapeutics, Inc.
(TVTX)
37,332
-10%
4,500
$31.49
$141,727.50
SELL
5 Feb 2021
REED ELIZABETH E
SVP, GC & Corporate Secretary, Officer
Travere Therapeutics, Inc.
(TVTX)
37,705
-10%
4,500
$31.49
$141,727.50
SELL
5 Feb 2021
Clague Laura
Chief Financial Officer, Officer
Travere Therapeutics, Inc.
(TVTX)
32,223
-12%
4,500
$31.49
$141,727.50
SELL
3 Feb 2021
Dube Eric M
Chief Executive Officer, Director, Officer
Travere Therapeutics, Inc.
(TVTX)
148,939
-1%
2,406
$28.91
$69,557.46
SELL
3 Feb 2021
Rosenberg Noah L.
Chief Medical Officer, Officer
Travere Therapeutics, Inc.
(TVTX)
44,657
-3%
1,813
$28.91
$52,413.83
SELL
3 Feb 2021
ROTE WILLIAM E.
Senior Vice President, R&D, Officer
Travere Therapeutics, Inc.
(TVTX)
38,457
-8%
3,625
$28.91
$104,798.75
SELL
3 Feb 2021
REED ELIZABETH E
SVP, GC & Corporate Secretary, Officer
Travere Therapeutics, Inc.
(TVTX)
38,380
-7%
3,175
$28.91
$91,789.25
SELL
3 Feb 2021
Clague Laura
Chief Financial Officer, Officer
Travere Therapeutics, Inc.
(TVTX)
33,348
-9%
3,625
$28.91
$104,798.75
SELL
2 Feb 2021
Heerma Peter
Chief Commercial Officer, Officer
Travere Therapeutics, Inc.
(TVTX)
57,094
-1%
1,126
$29.83
$33,588.58
SELL
2 Feb 2021
ASELAGE STEVE
Director
Travere Therapeutics, Inc.
(TVTX)
196,667
-11%
25,000
$30.75
$768,750.00
SELL
31 Jan 2021
Dube Eric M
Chief Executive Officer, Director, Officer
Travere Therapeutics, Inc.
(TVTX)
153,751
-5%
8,734
$29.91
$261,266.72
SELL
31 Jan 2021
Rosenberg Noah L.
Chief Medical Officer, Officer
Travere Therapeutics, Inc.
(TVTX)
46,470
-3%
1,813
$30.75
$55,749.75
SELL
31 Jan 2021
ROTE WILLIAM E.
Senior Vice President, R&D, Officer
Travere Therapeutics, Inc.
(TVTX)
40,957
-8%
3,625
$30.75
$111,468.75
SELL
31 Jan 2021
REED ELIZABETH E
SVP, GC & Corporate Secretary, Officer
Travere Therapeutics, Inc.
(TVTX)
41,555
-7%
3,175
$30.75
$97,631.25
SELL
31 Jan 2021
Clague Laura
Chief Financial Officer, Officer
Travere Therapeutics, Inc.
(TVTX)
36,973
-8%
3,625
$30.75
$111,468.75
SELL
5 Jan 2021
Dube Eric M
Chief Executive Officer, Director, Officer
Travere Therapeutics, Inc.
(TVTX)
87,819
-7%
6,876
$26.83
$184,483.08
SELL
5 Jan 2021
REED ELIZABETH E
SVP, GC & Corporate Secretary, Officer
Travere Therapeutics, Inc.
(TVTX)
24,055
-5%
1,376
$26.83
$36,918.08
SELL
15 Dec 2020
ASELAGE STEVE
Director
Travere Therapeutics, Inc.
(TVTX)
196,667
-2%
5,549
$26.02
$144,384.98
SELL
2 Dec 2020
ASELAGE STEVE
Director
Travere Therapeutics, Inc.
(TVTX)
202,216
-3%
7,891
$23.43
$184,849.05
SELL
23 Nov 2020
Clague Laura
Chief Financial Officer, Officer
Travere Therapeutics, Inc.
(RTRX)
19,473
-27%
7,500
$23.29
$174,675.00
SELL
16 Nov 2020
Clague Laura
Chief Financial Officer, Officer
Travere Therapeutics, Inc.
(RTRX)
19,473
-27%
7,500
$23.98
$179,812.50
SELL
16 Nov 2020
ROTE WILLIAM E.
Senior Vice President, R&D, Officer
Travere Therapeutics, Inc.
(RTRX)
24,086
-9%
2,500
$23.96
$59,900.00
SELL
16 Nov 2020
REED ELIZABETH E
SVP, GC & Corporate Secretary, Officer
Travere Therapeutics, Inc.
(RTRX)
25,431
-8%
2,500
$23.98
$59,950.00
SELL
11 Nov 2020
REED ELIZABETH E
SVP, GC & Corporate Secretary, Officer
Retrophin, Inc.
(RTRX)
27,931
-8%
2,500
$23.62
$59,045.50
SELL
11 Nov 2020
ROTE WILLIAM E.
Senior Vice President, R&D, Officer
Retrophin, Inc.
(RTRX)
26,586
-8%
2,500
$23.62
$59,056.00
SELL
11 Nov 2020
Clague Laura
Chief Financial Officer, Officer
Retrophin, Inc.
(RTRX)
26,973
-21%
7,500
$23.61
$177,071.25
SELL
5 Nov 2020
ASELAGE STEVE
Director
Retrophin, Inc.
(RTRX)
213,107
-9%
23,125
$22.81
$527,525.00
SELL
2 Oct 2020
Heerma Peter
Chief Commercial Officer, Officer
Retrophin, Inc.
(RTRX)
42,329
-9%
4,376
$19.13
$83,691.00
SELL
23 Sep 2020
Rosenberg Noah L.
Chief Medical Officer, Officer
Retrophin, Inc.
(RTRX)
27,555
-2%
750
$18.48
$13,860.00
SELL
23 Sep 2020
ROTE WILLIAM E.
Senior Vice President, R&D, Officer
Retrophin, Inc.
(RTRX)
24,086
-5%
1,500
$18.48
$27,720.00
SELL
23 Sep 2020
REED ELIZABETH E
SVP, GC & Corporate Secretary, Officer
Retrophin, Inc.
(RTRX)
25,431
-5%
1,500
$18.48
$27,720.00
SELL
23 Sep 2020
Clague Laura
Chief Financial Officer, Officer
Retrophin, Inc.
(RTRX)
19,473
-7%
1,500
$18.48
$27,720.00
SELL
18 Sep 2020
Dube Eric M
Chief Executive Officer, Director, Officer
Retrophin, Inc.
(RTRX)
96,260
-10%
10,805
$19.28
$208,319.38
SELL
18 Sep 2020
Rosenberg Noah L.
Chief Medical Officer, Officer
Retrophin, Inc.
(RTRX)
28,305
-2%
750
$18.59
$13,942.50
SELL
18 Sep 2020
ROTE WILLIAM E.
Senior Vice President, R&D, Officer
Retrophin, Inc.
(RTRX)
25,586
-5%
1,500
$18.59
$27,885.00
SELL
18 Sep 2020
REED ELIZABETH E
SVP, GC & Corporate Secretary, Officer
Retrophin, Inc.
(RTRX)
26,931
-5%
1,500
$18.59
$27,885.00
SELL
18 Sep 2020
Clague Laura
Chief Financial Officer, Officer
Retrophin, Inc.
(RTRX)
20,973
-6%
1,500
$18.59
$27,885.00
SELL
5 Aug 2020
ASELAGE STEVE
Director
Retrophin, Inc.
(RTRX)
236,232
-1%
2,500
$19.68
$49,200.00
SELL
28 Jul 2020
Rosenberg Noah L.
Chief Medical Officer, Officer
Retrophin, Inc.
(RTRX)
26,055
-3%
870
$20.49
$17,826.30
SELL
25 Jun 2020
ASELAGE STEVE
Director
Retrophin, Inc.
(RTRX)
238,732
-4%
10,000
$20.00
$200,000.00
SELL
12 May 2020
Rosenberg Noah L.
Chief Medical Officer, Officer
Retrophin, Inc.
(RTRX)
26,728
-1%
527
$16.98
$8,950.73
SELL
12 May 2020
ASELAGE STEVE
Director
Retrophin, Inc.
(RTRX)
245,732
-3%
8,125
$16.00
$130,039.41
SELL
11 May 2020
REED ELIZABETH E
SVP, GC & Corporate Secretary, Officer
Retrophin, Inc.
(RTRX)
25,958
-5%
1,577
$16.37
$25,808.48
SELL
11 May 2020
ROTE WILLIAM E.
Senior Vice President, R&D, Officer
Retrophin, Inc.
(RTRX)
24,021
-8%
2,152
$16.28
$35,039.00
SELL
11 May 2020
Clague Laura
Chief Financial Officer, Officer
Retrophin, Inc.
(RTRX)
20,000
-13%
3,027
$16.22
$49,088.23
SELL
5 May 2020
ASELAGE STEVE
Director
Retrophin, Inc.
(RTRX)
253,857
-0%
2,500
$15.88
$39,700.00
SELL
10 Mar 2020
ROTE WILLIAM E.
Senior Vice President, R&D, Officer
Retrophin, Inc.
(RTRX)
25,646
-11%
3,250
$14.87
$48,327.50
SELL
10 Mar 2020
REED ELIZABETH E
SVP, GC & Corporate Secretary, Officer
Retrophin, Inc.
(RTRX)
27,008
-11%
3,500
$15.02
$52,570.00
SELL
10 Mar 2020
Clague Laura
Chief Financial Officer, Officer
Retrophin, Inc.
(RTRX)
22,500
-15%
4,000
$15.02
$60,080.00
SELL
5 Mar 2020
Rosenberg Noah L.
Chief Medical Officer, Officer
Retrophin, Inc.
(RTRX)
27,255
-6%
1,790
$15.36
$27,487.24
SELL
5 Mar 2020
ASELAGE STEVE
Director
Retrophin, Inc.
(RTRX)
256,357
-1%
4,359
$15.36
$66,938.55
SELL
14 Feb 2020
ROTE WILLIAM E.
Senior Vice President, R&D, Officer
Retrophin, Inc.
(RTRX)
25,646
-8%
2,500
$16.63
$41,587.50
SELL
5 Feb 2020
ASELAGE STEVE
Director
Retrophin, Inc.
(RTRX)
248,466
-0%
2,500
$16.62
$41,550.00
SELL
7 Jan 2020
Dube Eric M
Chief Executive Officer, Director, Officer
Retrophin, Inc.
(RTRX)
42,500
-15%
7,500
$14.54
$109,050.00
SELL
7 Jan 2020
REED ELIZABETH E
SVP, GC & Corporate Secretary, Officer
Retrophin, Inc.
(RTRX)
18,008
-7%
1,500
$14.54
$21,810.00
SELL
29 Nov 2019
ASELAGE STEVE
Director
Retrophin, Inc.
(RTRX)
250,966
-1%
5,000
$13.91
$69,552.50
SELL
30 Jul 2019
Rosenberg Noah L.
Chief Medical Officer, Officer
Retrophin, Inc.
(RTRX)
13,500
-15%
2,500
$19.95
$49,862.50
SELL
15 May 2019
McFarlane Neil F.
Chief Operating Officer, Officer
Retrophin, Inc.
(RTRX)
26,988
-6%
1,968
$18.24
$35,906.16
SELL
15 May 2019
Clague Laura
Chief Financial Officer, Officer
Retrophin, Inc.
(RTRX)
13,500
-15%
2,500
$18.24
$45,612.50
SELL
14 May 2019
ROTE WILLIAM E.
Senior Vice President, R&D, Officer
Retrophin, Inc.
(RTRX)
18,185
-8%
1,625
$17.77
$28,876.26
SELL
14 May 2019
REED ELIZABETH E
SVP, GC & Corporate Secretary, Officer
Retrophin, Inc.
(RTRX)
19,508
-5%
1,050
$17.73
$18,616.50
SELL
14 May 2019
ASELAGE STEVE
Director
Retrophin, Inc.
(RTRX)
255,966
-1%
3,676
$17.81
$65,451.18
SELL
15 Feb 2019
ROTE WILLIAM E.
Senior Vice President, R&D, Officer
Retrophin, Inc.
(RTRX)
13,810
-15%
2,500
$21.48
$53,700.00
SELL
11 Feb 2019
REED ELIZABETH E
SVP, GC & Corporate Secretary, Officer
Retrophin, Inc.
(RTRX)
14,558
-10%
1,769
$21.44
$37,927.30
SELL
11 Feb 2019
ROTE WILLIAM E.
Senior Vice President, R&D, Officer
Retrophin, Inc.
(RTRX)
16,007
-11%
1,985
$21.44
$42,558.34
SELL
11 Feb 2019
Clague Laura
Chief Financial Officer, Officer
Retrophin, Inc.
(RTRX)
10,000
-16%
2,033
$21.44
$43,587.46
SELL
11 Feb 2019
ASELAGE STEVE
Chief Executive Officer, Director, Officer
Retrophin, Inc.
(RTRX)
257,642
-0%
2,130
$21.44
$45,667.20
SELL
8 Jan 2019
REED ELIZABETH E
SVP, GC & Corporate Secretary, Officer
Retrophin, Inc.
(RTRX)
16,327
-8%
1,500
$23.96
$35,932.50
SELL
20 Dec 2018
McFarlane Neil F.
Chief Operating Officer, Officer
Retrophin, Inc.
(RTRX)
35,360
-23%
11,125
$22.32
$248,333.19
SELL
20 Dec 2018
ASELAGE STEVE
Chief Executive Officer, Director, Officer
Retrophin, Inc.
(RTRX)
260,672
-4%
12,376
$21.88
$270,787.84
SELL
20 Dec 2018
Clague Laura
Chief Financial Officer, Officer
Retrophin, Inc.
(RTRX)
12,933
-36%
7,500
$21.96
$164,664.70
SELL
7 Dec 2018
ASELAGE STEVE
Chief Executive Officer, Director, Officer
Retrophin, Inc.
(RTRX)
251,523
-0%
10
$24.04
$240.37
SELL
14 Nov 2018
McFarlane Neil F.
Chief Operating Officer, Officer
Retrophin, Inc.
(RTRX)
29,476
-25%
10,000
$23.73
$237,314.40
SELL
14 Nov 2018
REED ELIZABETH E
SVP, GC & Corporate Secretary, Officer
Retrophin, Inc.
(RTRX)
18,027
-21%
5,000
$24.03
$120,145.94
SELL
14 Nov 2018
ROTE WILLIAM E.
Senior Vice President, R&D, Officer
Retrophin, Inc.
(RTRX)
18,304
-21%
5,000
$24.03
$120,129.55
SELL
14 Nov 2018
Clague Laura
Chief Financial Officer, Officer
Retrophin, Inc.
(RTRX)
12,824
-36%
7,500
$24.02
$180,137.52
SELL
14 Nov 2018
ASELAGE STEVE
Chief Executive Officer, Director, Officer
Retrophin, Inc.
(RTRX)
254,369
-4%
11,100
$24.03
$266,703.44
SELL
31 Aug 2018
ASELAGE STEVE
Chief Executive Officer, Director, Officer
Retrophin, Inc.
(RTRX)
245,883
-4%
12,000
$32.00
$384,000.00
SELL
14 Feb 2018
ROTE WILLIAM E.
Senior Vice President, R&D, Officer
Retrophin, Inc.
(RTRX)
11,156
-8%
1,034
$21.50
$22,232.03
SELL
5 Jan 2018
REED ELIZABETH E
SVP, GC & Corporate Secretary, Officer
Retrophin, Inc.
(RTRX)
9,058
-9%
942
$24.04
$22,645.68
SELL
16 Aug 2017
McFarlane Neil F.
Chief Operating Officer, Officer
Retrophin, Inc.
(RTRX)
13,622
-9%
1,378
$22.50
$31,005.00
SELL
14 Jun 2017
ASELAGE STEVE
Chief Executive Officer, Director, Officer
Retrophin, Inc.
(RTRX)
245,556
-1%
5,000
$17.85
$89,250.00
SELL
21 Nov 2016
ASELAGE STEVE
Chief Executive Officer, Director, Officer
Retrophin, Inc.
(RTRX)
240,556
-3%
8,200
$21.12
$173,160.00
SELL
1 Sep 2016
Shih Alvin
EVP of Research & Development, Officer
Retrophin, Inc.
(RTRX)
158,334
-5%
8,750
$16.24
$142,058.88
SELL
1 Jun 2016
Shih Alvin
EVP of Research & Development, Officer
Retrophin, Inc.
(RTRX)
167,084
-4%
8,750
$17.75
$155,283.62
BUY
4 Mar 2016
Meckler Jeffrey A
Director
Retrophin, Inc.
(RTRX)
52,000
+10%
5,000
$15.31
$76,564.50
BUY
3 Mar 2016
Meckler Jeffrey A
Director
Retrophin, Inc.
(RTRX)
47,000
+27%
10,000
$14.45
$144,500.00
SELL
1 Mar 2016
Shih Alvin
EVP of Research & Development, Officer
Retrophin, Inc.
(RTRX)
175,834
-4%
8,750
$14.35
$125,568.63
Home